Similarly, LPA from ovarian cancer cells increases VEGF secretion in ASC [19], but the use of cell-conditioned media containing a plethora of signaling molecules and biologically variant concentrations of LPA is confounding and thus not ideal for therapeutic angiogenesis. Here, VEGFA is linked to ovarian cancer.